Global Infectious Disease Biomarker Testing Market Is Expected to Reach $15.01 Billion in 2030

According to the study published by BIS Research, Global infectious disease biomarker testing market was valued at $5.64 billion in 2019 and is expected to reach $15.01 billion in 2030, witnessing a CAGR of 14.48% during the forecast period between 2020 and 2030.
View the Report: https://bisresearch.com/industry-report/infectious-disease-biomarker-testing-market.html
The global infectious disease biomarker testing market is growing at a progressive rate, owning to the growing infectious disease burden in addition to other factors such as rising health awareness, the increasing involvement of patients in personal healthcare, and the technological advancements transpired in the biomarkers field, among others. Further, the recent outbreak of the novel coronavirus has resulted in an upsurge in demand for biomarker testing products for the detection of SARS-CoV-2, positively impacting the growth of the market. Several new companies have also ventured into the market, and other established players have also engaged in several business strategies, including collaboration, partnership, and acquisition, in order to strengthen their business position in the market.
Request for a Sample: https://bisresearch.com/requestsample?id=876&type=download
This growth of the global infectious disease biomarker testing market is primarily attributed to the major drivers in this market such as a highly increasing global prevalence of infectious diseases, growth in the biomarker identification market and advancements in molecular techniques, rapid advances in biomarker testing platforms with improved speed, sensitivity, and patient compliance, and significant external funding for executing research and development exercises.
Key Questions Answered in the Report:
• What is a biomarker and what is the importance of biomarker testing?
• What are the different biomarker testing approaches for infectious diseases? What are utilities associated with clinical biomarkers and what are the different types of biomarker available for commercial application?
• What are the major advancements in infectious disease biomarker testing market? What are the key trends of the global infectious disease biomarker testing market? How is the market evolving and what is its future scope?

Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

About BIS Research:
BIS Research (Business Intelligence and Strategy Research) is a global B2B market intelligence and advisory firm which focuses on those emerging trends in technology which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials & Chemicals, Aerospace and Defence, Automotive, Healthcare, Electronics & Semiconductors, Robotics & UAV and other emerging technologies.
Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data and other important market parameters useful in the strategic decision making for senior management.
What distinguishes BIS Research from the rest of the players is that we don’t simply provide data, but also complement it with valuable insights and actionable inputs for the success of our clients.

This release was published on openPR.